Advertisement

Topics

Prommune Inc., announces results of a study on its lead products, HeptaVac™ and HISP-P™ for ...

19:49 EDT 24 Aug 2017 | BioMedReports - Blog

HeptaVac was designed to elicit cellular immunity and contains antigenic peptides from the H1N1 influenza virus proteins, two of which represent conserved sequences between

Read more...

Original Article: Prommune Inc., announces results of a study on its lead products, HeptaVac™ and HISP-P™ for ...

NEXT ARTICLE

More From BioPortfolio on "Prommune Inc., announces results of a study on its lead products, HeptaVac™ and HISP-P™ for ..."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Immunology
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...

Influenza
Influenza or 'flu' is a respiratory illness associated with infection by influenza virus. Symptoms frequently include headache, fever, cough, sore throat, aching muscles and joints. There is a wide spectrum of severity of illness ranging from min...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...